Buy HepCvir L : Ledipasvir & Sofosbuvir Tablets Online
Brand Name : HepCvir L
Composition : Ledipasvir & Sofosbuvir
Manufactured by : Gilead Sciences Ireland UC
Marketed by : Cipla Ltd.
Strength : Ledipasvir 90 mg and Sofosbuvir 400 mg
Form : Tablets
Packing : Pack of 28 Tablets
Prescription Required *
HepCvir L, marketed under the brand name HepCvir L, is a medication in tablet form. It is composed of Ledipasvir 90 mg and Sofosbuvir 400 mg. HepCvir L is manufactured by Gilead Sciences Ireland UC and marketed by Cipla Ltd. This medication is primarily used to treat hepatitis C viral infection in adults.
HepCvir L is primarily prescribed for the treatment of chronic hepatitis C infection in adults. It is used in combination with other antiviral medications to effectively combat the hepatitis C virus and prevent its replication in the body. The treatment duration and regimen may vary based on individual factors and the specific genotype of the hepatitis C virus.
How to use:
HepCvir L should be taken exactly as prescribed by the healthcare professional. It is typically taken orally once a day with or without food. Swallow the tablet whole with a glass of water. Do not chew, crush, or split the tablet. It is important to complete the full course of treatment as directed, even if symptoms improve before completion.
Store HepCvir L at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets. Do not store it in the bathroom or in extreme cold or heat.
Mechanism of action:
HepCvir L contains two active ingredients, Ledipasvir and Sofosbuvir. Ledipasvir is a hepatitis C virus NS5A inhibitor, and Sofosbuvir is a nucleotide analog inhibitor of the hepatitis C virus NS5B polymerase. These medications work together to stop the hepatitis C virus from multiplying and spreading, ultimately leading to a decrease in the viral load in the body.
Before using HepCvir L, inform your doctor about any known allergies, medical conditions, or significant medical history. It is crucial to disclose all medications, supplements, and herbal remedies you are currently taking to avoid potential interactions. HepCvir L may not be suitable for individuals who have severe liver or kidney problems, are pregnant, planning to become pregnant, or breastfeeding.
HepCvir L is contraindicated in individuals with known hypersensitivity to Ledipasvir, Sofosbuvir, or any of the other components of the medication.
Inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter drugs, herbal supplements, and vitamins. Certain medications may interact with HepCvir L, altering its effectiveness, or increasing the risk of side effects. Your doctor will assess and provide necessary guidance regarding potential drug interactions.
In the case of an overdose, seek immediate medical attention or contact a poison control center. The symptoms of an overdose may include severe fatigue, nausea, vomiting, abdominal pain, and dizziness.
Common side effects of HepCvir L may include fatigue, headache, nausea, diarrhea, and difficulty sleeping. If these side effects persist or worsen, inform your doctor promptly. Serious side effects are rare but may include signs of liver problems, severe allergic reactions, and changes in mood or behavior. If you experience any severe or persistent side effects, seek immediate medical assistance.